Abstract:
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Abstract:
A method is disclosed for coating a positive active material of a lithium-ion battery. The method includes the step of dissolving at least one salt that contains a coating metal in a solvent to provide a solution, the step of dissolving a lithium-containing positive active material in the solution and adjusting the pH value of the solution to deposit M(OH)2n on the lithium-containing positive active material, the step of drying the M(OH)2n and the lithium-containing positive active material, and the step of sintering the M(OH)2n and the lithium-containing positive active material to coat the lithium-containing positive active material with MOn.
Abstract:
The present invention provides compounds of Formula (I), including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Abstract:
The improved milling machine makes use of individually controlled x-axis, y-axis, and z-axis carriages. These carriages provide positive and precise control of the position of the cutting tools and the blank to be cut. A tool changer allows the tools to be changed to accommodate other materials. A camera is used to detect wear on the tools.
Abstract:
Compounds for treating abuse of nicotinic receptor agonists, addiction to psychostimulant drugs, addiction to opiates, addiction to alcohol, addiction to tobacco products, addiction to nicotine, schizophrenia and related diseases, depression and related conditions, Alzheimer's disease, Parkinson's disease, irritable bowel syndrome, and colitis. The compounds competitively inhibit central nervous system acting nicotinic receptor agonists and act at the putative α3β2* and α4β2 neuronal nicotinic receptors in the central nervous system.
Abstract:
Pharmaceutical compounds comprising bridged nicotine analogs of N-octylnicotinium iodide (NONI) having selective antagonist properties at &agr;3&bgr;2-containing nicotinic receptor subtypes, and compositions containing these compounds. The compounds and compositions are used to treat central nervous system pathologies.
Abstract:
The present invention discloses a debris collection device for cutting mechanism and an LCD panel cutting debris suction device. A debris collection device for cutting mechanism comprises a debris collection cap and a suction spray head used for connecting with a suction device; the debris collection cap comprises a connecting part used for surrounding and fixing on the cutting mechanism, and the debris collection cap is provided with a through hole communicated with the suction spray head. The present invention can remove the debris produced in the cutting process in time, and can reduce relevant defects such as line scratches, terminal scratches, short circuit, broken circuit, etc. which are generated because of debris. Thus, the product yield and quality of LCD panels can be improved, and the time of the subsequent cleaning process can be reduced.
Abstract:
A wet limestone flue gas desulfurization slurry stabilizer and a method for using the same are disclosed. The stabilizer consists of lime, sodium formate and an antifoaming agent, the components and mass percentages thereof are as follows: lime, 30% to 70%, sodium formate, 15% to 40%, the antifoaming agent, 15% to 40%. The method for using the desulfurization slurry stabilizer comprises: preparing the slurry stabilizer into a homogeneous liquid having a mass concentration of 10% to 30% with water or desulfurization slurry outside a desulfurization tower, and spraying the homogeneous liquid into the absorption area and the reaction area of the desulfurization tower using a pump and a slurry atomizing and spraying device.
Abstract:
Compounds of Formula I: and salts thereof in which R1, R2, R2a, R3, n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.
Abstract:
The present invention provides a compound and pharmaceutically acceptable salts thereof, comprising the Formula I. Also provided are methods of using the compound of this invention as an AKT protein kinase inhibitor and for the treatment of hyperproliferative diseases such as cancer.